Bristol Myers Squibb CEO Caforio collected $20M in 2020 pay amid Celgene integration, pandemic challenges

Bristol Myers Squibb has been busy weathering the pandemic, but the company's leadership has also been tasked with integrating Celgene after a huge buyout. And for his work in guiding the drugmaker last year, CEO Giovanni Caforio collected a pay package worth more than $20 million.